Literature DB >> 19942739

Role of connexin 26 (GJB2) & mitochondrial small ribosomal RNA (mt 12S rRNA) genes in sporadic & aminoglycoside-induced non syndromic hearing impairment.

Hema Bindu Lingala1, Pardhanandana Reddy Penagaluru.   

Abstract

Non syndromic hearing impairment is a common sensory disorder, which affects one in 600 newborns. Though more than 50 nuclear genes are involved in causing non syndromic hearing impairment, mutations in the connexin 26 (GJB2) gene explain a high proportion of congenital deafness in several populations worldwide. The diversity of genes and genetic loci implicated in hearing loss defines the complexity of the genetic basis of hearing. This review focuses on the role of connexin 26 and mitochondrial 12S rRNA genes in hearing which will be helpful for better understanding of genes in sporadic and aminoglycoside-induced non syndromic hearing impairment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19942739

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  4 in total

1.  Prospective variants screening of connexin genes in children with hearing impairment: genotype/phenotype correlation.

Authors:  Jiann-Jou Yang; Wen-Hung Wang; Yen-Chun Lin; Hsu-Huei Weng; Jen-Tsung Yang; Chung-Feng Hwang; Che-Min Wu; Shuan-Yow Li
Journal:  Hum Genet       Date:  2010-07-01       Impact factor: 4.132

2.  A Structured Brain-wide and Genome-wide Association Study Using ADNI PET Images.

Authors:  Yanming Li; Bin Nan; Ji Zhu
Journal:  Can J Stat       Date:  2021-02-20       Impact factor: 0.875

3.  Molecular investigation of pediatric portuguese patients with sensorineural hearing loss.

Authors:  Célia Nogueira; Miguel Coutinho; Cristina Pereira; Alessandra Tessa; Filippo M Santorelli; Laura Vilarinho
Journal:  Genet Res Int       Date:  2011-09-25

4.  Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects.

Authors:  Valeria Guaran; Laura Astolfi; Alessandro Castiglione; Edi Simoni; Elena Olivetto; Marco Galasso; Patrizia Trevisi; Micol Busi; Stefano Volinia; Alessandro Martini
Journal:  Int J Mol Med       Date:  2013-08-16       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.